| LDR | | 01615nmm uu200397 4500 |
| 001 | | 000000333798 |
| 005 | | 20240805174546 |
| 008 | | 181129s2017 |||||||||||||||||c||eng d |
| 020 | |
▼a 9780438098725 |
| 035 | |
▼a (MiAaPQ)AAI10901934 |
| 035 | |
▼a (MiAaPQ)OhioLINK:osu1502908907944535 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 248032 |
| 082 | 0 |
▼a 615 |
| 100 | 1 |
▼a Mody, Hardik Rameshchandra. |
| 245 | 10 |
▼a Investigation of Micro-RNA-based Approaches to Overcome Epithelial-Mesenchymal Transition in Pancreatic Cancer. |
| 260 | |
▼a [S.l.] :
▼b The Ohio State University.,
▼c 2017 |
| 260 | 1 |
▼a Ann Arbor :
▼b ProQuest Dissertations & Theses,
▼c 2017 |
| 300 | |
▼a 255 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 79-12(E), Section: B. |
| 500 | |
▼a Adviser: Rajgopal Govindarajan. |
| 502 | 1 |
▼a Thesis (Ph.D.)--The Ohio State University, 2017. |
| 520 | |
▼a Pancreatic Cancer is one of the most devastating type of cancers with an extremely poor 5-year survival rate of about 7%. This is largely due to the metastatic ability of pancreatic cancers which renders approved drugs like gemcitabine ineffecti |
| 590 | |
▼a School code: 0168. |
| 650 | 4 |
▼a Pharmacology. |
| 650 | 4 |
▼a Pharmaceutical sciences. |
| 690 | |
▼a 0419 |
| 690 | |
▼a 0572 |
| 710 | 20 |
▼a The Ohio State University.
▼b Pharmaceutical Sciences. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 79-12B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0168 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2017 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T15000332
▼n KERIS |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a 관리자 |